Brookstone Capital Management Has $8.34 Million Stock Position in Synopsys, Inc. $SNPS

Brookstone Capital Management boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 16.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,033 shares of the semiconductor company’s stock after buying an additional 2,996 shares during the period. Brookstone Capital Management’s holdings in Synopsys were worth $8,339,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Sankala Group LLC bought a new stake in Synopsys during the 4th quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Synopsys during the 4th quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd bought a new stake in Synopsys during the fourth quarter worth $28,000. Atlas Capital Advisors Inc. bought a new stake in shares of Synopsys during the 4th quarter worth $32,000. Finally, Phillip James Consulting Co. purchased a new position in shares of Synopsys in the 4th quarter worth about $36,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Synopsys Price Performance

NASDAQ SNPS opened at $464.58 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The company has a market cap of $88.96 billion, a PE ratio of 107.54, a price-to-earnings-growth ratio of 2.68 and a beta of 1.22. Synopsys, Inc. has a 52 week low of $376.18 and a 52 week high of $651.73. The firm’s 50-day simple moving average is $480.33 and its two-hundred day simple moving average is $462.32.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company’s revenue was up 41.9% on a year-over-year basis. During the same quarter last year, the company earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Wall Street Analysts Forecast Growth

SNPS has been the subject of several research reports. Bank of America increased their price target on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Piper Sandler boosted their target price on shares of Synopsys from $430.00 to $450.00 and gave the company a “neutral” rating in a research note on Thursday, May 28th. The Goldman Sachs Group set a $600.00 target price on shares of Synopsys and gave the company a “buy” rating in a research report on Wednesday, February 25th. Stifel Nicolaus raised their price target on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, Wells Fargo & Company upped their price objective on Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a research note on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $563.81.

Insiders Place Their Bets

In other news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.